No significant difference of IFN-γ/IL-4 ratio of α-GalCer treated iNKT cells in SLE patients was noted after addition of IL-15 (1.9±0.2% vs. 1.8±0.2%, p = 1.000). This evidence concerns the gene IL15 and systemic lupus erythematosus.